Best phaco disinfection techniques

Article

Three-day application of levofloxacin in the presence of polyvinyl alcohol-iodine or povidone iodine offers the best infection control in phaco patients, according to a study published in the May 2008 issue of the Japanese Journal of Ophthalmology.

Three-day application of levofloxacin in the presence of polyvinyl alcohol-iodine or povidone iodine offers the best infection control in phaco patients, according to a study published in the May 2008 issue of the Japanese Journal of Ophthalmology.

Yoshitsugu Inoue of the Division of Ophthalmology and Visual Science, Faculty of Medicine, Tottori University Yonago, Tottori, Japan and colleagues assessed preoperative disinfection methods to determine which method encouraged optimal duration of levofloxacin (LVFX), comparing povidone-iodine (PI) solution with polyvinyl alcohol-iodine (PAI), in elderly patients undergoing phacoemulsification aspiration and intraocular lens (IOL) implantation (n=272).

Subjects were randomized into six groups: three groups received three-day, one-day and one-hour preoperative applications of LVFX with PI eye wash, respectively; the remaining three groups received three-day, one-day and one-hour preoperative applications of LVFX with PAI eye wash, respectively. Subjects' corneas were scraped before and after LVFX application, after eyewash application and after surgery. Aqueous humour samples were also collected postoperatively.

The researchers found that, across all groups, three-day LVFX application was the more effective disinfectant method and PAI had a marginally higher rate of disinfection than PI: 79.4% and 78.0%, respectively. After LVFX and PAI/PI application, however, new isolates were detected.

The team concluded that, preoperatively, the best disinfection method is three-day application of LVFX with either PAI or PI solution, although it is unlikely that these disinfectants will eliminate bacteria entirely.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.